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S U M M A R Y
Background: During the years 2014 and 2015, the Region of the Americas underwent a devastating
epidemic of chikungunya virus (CHIKV) of the Asian genotype, resulting in millions of affected
individuals. However, epidemiological and clinical information on this experience is scarce. Prior
knowledge of congenital and neonatal illness caused by CHIKV is limited and almost exclusively based
on data obtained from a single outbreak of the East/Central/South African (ECSA) genotype. The effect of
chikungunya fever (CHIKF) on pregnancy outcomes and its consequences for infants born to infected
mothers at the peak of the epidemic wave in Latin America are reviewed herein. Epidemiological and
clinical data on maternal and neonatal infections were collected prospectively and analyzed.
Methods: One hundred sixty-nine symptomatic newborns with CHIKF seen at four large regional
maternity hospitals in three different Central and South American countries were evaluated
prospectively. The outcomes of pregnancies in symptomatic infected mothers at two of these clinical
centers were also analyzed.
Results: The observed vertical transmission rate ranged between 27.7% and 48.29%. The incidence of
congenital disease was unrelated to the use of cesarean section or natural delivery. The case fatality rate
(CFR) at the only center that reported deaths was 5.3%. The most common clinical manifestations
included fever, irritability, rash, hyperalgesia syndrome, diffuse limb edema, meningoencephalitis, and
bullous dermatitis. Severe complications included meningoencephalitis, myocarditis, seizures, and acute
respiratory failure. Leukocytosis with neutrophilia and normal or increased platelets was a common
ﬁnding, and in those with signs of meningeal involvement, moderate lymphocytic pleocytosis with
normal glucose and protein levels was typical.
Conclusions: This study presents the largest number of symptomatic neonates with CHIKF analyzed so
far in any region and is the ﬁrst involving infection with the Asian genotype of CHIKV. Although the
clinical manifestations found were similar to those reported previously, the percentage of neurological
complications was lower. The CFR was comparatively high. Chikungunya represented a substantial risk
for neonates born to symptomatic parturients during the chikungunya outbreak in the Americas Region,
with important clinical and public health implications.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Little is known of the risk and impact of mother-to-child
transmission of chikungunya virus (CHIKV). Most of our present
knowledge is derived from the experience of the large outbreak
caused by the East/Central/South African (ECSA) genotype in La
Re´union Island, where perinatal infection, as well as the clinicalciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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described for the ﬁrst time.1–3
Since December 2013, a large epidemic of chikungunya fever
(CHIKF) caused by the Asian genotype of CHIKV has affected the
Caribbean and Central and South America, with over 1.5 million
cases of the disease reported from more than 20 countries.4 A
recent report by Villamil-Go´mez et al., emphasizes the threat to
maternal and child health in the Americas, describing a case series
of eight severely ill newborns with documented congenital CHIKF
seen at a private health facility in the city of Sincelejo, Sucre
Department, Colombia.5
The aim of this study was to determine the effect of CHIKF on
pregnancy outcomes and its consequences for infants born to
infected mothers in the Americas. Information was collected from
four large regional maternity hospitals in three countries of the
region. The epidemiological and clinical data pertaining to
maternal and neonatal infections observed at the peak of the
epidemic wave are analyzed herein.
2. Materials and methods
Prospective clinical and epidemiological data collected from
all symptomatic pregnant women and newborns with a
conﬁrmed diagnosis of CHIKF, seen at two large reference
hospitals in El Salvador from August to October 2104, were
reviewed. All patients had either one CHIKV end-point conven-
tional PCR or reverse transcriptase (RT)-PCR conﬁrmatory result,
or else a CHIKV monoclonal antibody-based IgM capture ELISA
test performed at a diagnostic reference laboratory. Relevant
information was supplemented by data collected from the
Epidemiological Surveillance System of the Ministry of Health
of El Salvador (VIGEPES), as well as through personal communi-
cation with Dr Julio Armero of the Pediatric Department of
Zacamil National Hospital and ‘‘Hospital Nacional de la Mujer’’,
San Salvador, El Salvador.
All newborns admitted to the University Hospital ‘‘Hernando
Moncaleano Perdomo’’, in Neiva, Colombia, whose mothers had
documented or suspected clinical CHIKF from January 1 to
March 31, 2015, after the ofﬁcial declaration of the chikungunya
outbreak situation in the municipality, were evaluated prospec-
tively. The clinical information obtained for 35 newborns
with characteristic clinical manifestations suspected of having
CHIKF, as well as for two severely ill patients with laboratory
conﬁrmation of CHIKV infection by CHIKV RT-PCR, were
analyzed.
Prospective and retrospective clinico-epidemiological data
from symptomatic pregnant women and newborns seen at the
Maternity Hospital ‘‘Nuestra Sen˜ora de La Altagracia’’, Santo
Domingo, Dominican Republic, from May to August 2014, were
provided by Dr Luis Rivera Mejı´a. Standard Pan American Health
Organization chikungunya fever case deﬁnitions and clinical
classiﬁcation were used.6 A suspected case was any symptom-
atic newborn from a mother with acute onset of fever >38.5 8C
and severe arthralgia/arthritis during the previous 2 weeks, not
explained by other medical conditions, residing or having visited
epidemic areas with reported transmission within 15 days prior
to the onset of symptoms. No conﬁrmatory tests for CHIKV
infection were widely available in the country during the study
period.
In general, CHIKF was considered as a vertical mother-to-child
transmission when symptoms occurred during the ﬁrst week of
life, in the absence of evidence of a mosquito bite.
Fisher’s exact test was used to determine non-
random associations between two categorical variables when
applicable.3. Results
One hundred ninety-one symptomatic pregnant women with
CHIKV infection conﬁrmed by speciﬁc serology or PCR were
followed prospectively and their pregnancy outcomes assessed at
two different public medical centers in San Salvador, El Salvador
(Hospital Nacional de la Mujer, and Hospital Nacional Zacamil). A
total of 53 CHIKV-infected newborns, conﬁrmed by either
conventional end-point PCR or RT-PCR, were identiﬁed and
clinically followed in the Pediatric Department of Zacamil National
Hospital and ‘‘Hospital Nacional de la Mujer’’, located in the same
city.
All women were in the third trimester of pregnancy (mean
gestational age 38.2 weeks, range 35–40 weeks). Maternal age
ranged from 14 to 30 years (mean 22.8 years). A total of
53 newborns developed a congenital infection conﬁrmed by
speciﬁc CHIKV RT-PCR (vertical transmission rate 27.7%). Prema-
ture delivery occurred in 17 cases (8.9%), but no miscarriages were
observed. The average weight of affected newborns was 3.1 kg.
The predominant clinical manifestations in symptomatic
newborns were fever (100%), irritability (90%), rash (84%),
generalized edema (86%), hyperalgesia (94%), stiff neck or pain
on mobilization (38%), and hemodynamic instability (52%).
Relevant abnormal hematological parameters included hemoglo-
bin (median 15.8 g/dl, range 12.0–20.1 g/dl), leukocytes (median
18.24  109/l, range 3.53–37.29  109/l), neutrophils (mean
13.27  109/l, range 2.27–27.69  109/l), percentage of bands
(median 4%, range 0–30%), and platelets (median 242.0  109/l,
range 88–372  109/l). Moderate thrombocytopenia was observed
in two patients.
Thirty-seven symptomatic neonates (24 male, 13 female) born
to mothers with documented (20 patients) or suspected
(17 patients) clinical CHIKF, were evaluated at the service of
Neonatal Basic Care and/or Neonatal Intensive Care Unit of the
University Hospital ‘‘Hernando Moncaleano Perdomo’’, in Neiva,
Colombia. Other confounding acute viral and bacterial infections
were excluded in all newborns, either by conventional serology or
by culture. Rapid tests for dengue (Ad-bio Rapid Ag dengue CE and
Duo IgG/IgM rapid test CE; CTK Biotech, San Diego, CA, USA) were
routinely performed, and all cases were negative. Zika serology
was not included, as circulation of the virus was not known to be
occurring on the continent at that time.
The mean duration of fever was 3 days (range 1–5 days), and the
average length of hospital stay was 3.9 days (range 1–11 days). The
most common clinical ﬁndings were exanthema (97.2%), lower
extremity edema (27%), diffuse hyperalgesia syndrome (13.5%),
diarrhea (19%), distal cyanosis (8.1%), diffuse abdominal pain
(8.1%), and bullous dermatosis (5.4%). Two of these babies
developed severe myocarditis, with echocardiographic evidence
of ventricular dysfunction. Both recovered uneventfully. In both
cases, conventional CHIKV RT-PCR performed on serum obtained
early in the course of the illness was positive. Another newborn
had a generalized seizure, with normal cerebrospinal ﬂuid results
and no evidence of neurological sequelae.
At ‘‘Nuestra Sen˜ora de La Altagracia’’ Maternity Hospital in
Santo Domingo, Dominican Republic, 205 pregnant women with
symptoms of CHIKF, classiﬁed as suspected cases, as deﬁned
previously (see above), were evaluated. A total of 99 newborns
developed symptoms suggestive of the condition. All of them had
fever, poor feeding, and irritability, in combination with any of the
following: rash, hyperalgesia/allodynia, diffuse lower limb edema,
dermatosis bullosa/skin scaling, meningoencephalitis, respiratory
failure, hyperpigmentation, or myocarditis. Of note, 85 (85.85%) of
them became ill on the ﬁfth day after birth. Although conﬁrmatory
tests for CHIKV infection were not available, other confounding
acute viral infections including dengue, as well as bacterial
Table 2
Lumbar puncture results for 22 neonates with chikungunya fever and clinical
ﬁndings of meningoencephalitis, seen at the Pediatric Department of Zacamil
National Hospital and ‘‘Hospital Nacional de la Mujer’’, San Salvador, El Salvador
CSF cytochemical parameter Mean value Range
Glucose, mg/dl 57 45–80
WBC count, 106 cells/l 158 32–376
Percentage of lymphocytes 64% 38–89%
Proteins, mg/dl 68 38–69
CSF, cerebrospinal ﬂuid; WBC, white blood cell count.
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serology or by culture. Zika virus was not present in the population
during the period of observation. The vertical transmission rate
was 48.29% (99 symptomatic neonatal infections out of
205 mothers). Caesarean sections were performed in 59 of the
99 symptomatic mothers (74.6%). The incidence of congenital
disease in newborns was statistically unrelated to cesarean
delivery (Fisher’s exact test, p > 0.05).
Seventy-nine infected newborns with typical signs of acute
CHIKF could be evaluated prospectively in detail. The onset of
symptoms in all of these children occurred between days 3 and
9 after birth (median day 5). Fever, difﬁculty in feeding, and
irritability were documented in all patients. A rash was seen in
43.0% of cases, diffuse edema of the extremities in 41.8%, bullous
dermatosis and/or intense skin scaling in 8.9%, and hyperpigmen-
tation in 5.1%. Other relevant clinical ﬁndings included diffuse
hyperalgesia syndrome in 57.0%, acute respiratory failure in 10.1%,
meningoencephalitis in 1.2%, and myocarditis in 1.2%. In none of
the newborns were congenital malformations identiﬁed.
Four out of 79 newborns died (including a pair of twins), giving
a case fatality rate (CFR) of 5.1%. The cause of death was extreme
low birth weight and acute respiratory distress syndrome in two
newborns, meconium aspiration with congenital pneumonia in
one, and extreme low birth weight with intraventricular hemor-
rhage in the other.
The comparative and combined results of the clinical ﬁndings
observed in these 169 neonates with conﬁrmed (55 cases) or
suspected (114 cases) CHIKV infection, seen at four medical
institutions in three different Latin American countries, are shown
in Table 1. Rash, hyperalgesia or allodynia, and meningoencephali-
tis were the only clinical ﬁndings observed signiﬁcantly less often
in the unconﬁrmed suspected cases at Nuestra Sen˜ora de
Altagracia Maternity Hospital, as compared to those conﬁrmed
at the other clinical centers studied (Fisher’s exact test p-value of
<0.0001).
Twenty-two neonates with a conﬁrmed infection underwent
lumbar puncture. Results were abnormal in 10 of them, with
cytochemical analysis of the cerebrospinal ﬂuid (CSF) revealing
consistently normal levels of glucose, elevated leukocytes (median
158  106/l, range 32–376  106/l) with a predominance of
lymphocytes (median 64%, range 38–89%), and normal proteins
(median 68 mg/dl, range 38–69 mg/dl). The speciﬁc CHIKV RT-PCR
test of CSF was positive in two cases (Table 2).Table 1
Clinical characteristics of 169 neonates with chikungunya fever seen at the Maternity Ho
University Hospital ‘‘Hernando Moncaleano Perdomo’’ in Neiva, Colombia, and the Pediat
San Salvador, El Salvador
Zacamil National Hospital and
‘‘Hospital Nacional de la Mujer’’,
El Salvador
n = 53
‘‘Nuest
Matern
Domin
n = 79
Clinical ﬁnding n (%) n (%) 
Fever 53 (100%) 79 (10
Poor feeding 52 (98.1%) 79 (10
Irritability 48 (90.6%) 79 (10
Rasha 45 (84.9%) 34 (43
Hyperalgesia/allodyniaa 50 (94.3%) 45 (57
Diffuse lower limb edema 46 (86.8%) 33 (41
Hemodynamic instability 28 (52.8%) - 
Dermatosis bullosa/skin scaling 8 (15.1%) 7 (8.9
Respiratory failure 4 (7.5%) 8 (10
Meningoencephalitisa 10 (18.86%) 1 (1.2
Hyperpigmentation - 4 (5.1
Myocarditis - 1 (1.2
a Fisher’s exact test p < 0.0001 for differences between ‘‘Nuestra Sen˜ora de La Altagraci
other three clinical centers.4. Discussion
Mother-to-child transmission of CHIKV was reported during
the large 2005–2006 outbreak on La Re´union Island, France.7
Maternal–fetal transmission almost invariably occurs in the
setting of maternal viremia concomitant with delivery. As shown
in the present series of patients, a cesarean section does not appear
to prevent vertical transmission of CHIKV; therefore, the system-
atic performance of cesarean sections for infected mothers in order
to reduce the risk of viral transmission should not be recom-
mended.8–10 Close monitoring of viremic parturients and delivery
in maternity facilities with adequate obstetric and neonatal care is
advised.
Early maternal–fetal transmission of CHIKV, before 16 weeks of
gestation, has resulted in fetal deaths with no malformations, with
the presence of viral genome in the amniotic ﬂuid, placenta, and/or
brain of the fetuses.9
When maternal infection occurs at the end of pregnancy, about
12% of newborns are expected to be symptomatic and most of
them will develop severe manifestations such as meningoenceph-
alitis and intravascular coagulation, requiring a prolonged neona-
tal hospitalization and/or intensive care.10–12 This may be due in
part to the higher viral concentrations observed in this age
group.10–12
Of note, conjunctivitis – a common ﬁnding in adults and older
children – was not observed in any of the newborns in this series of
cases. Furthermore, thrombocytopenia, which has been reported in
up to 89% of infected neonates,13 was a very unusual ﬁnding (1.2%)
in the patients in this study.
In the context of outbreaks, CHIKV may represent a signiﬁcant
cause of central nervous system disease in children. Indeed, a
cumulative incidence rate (CIR) per 100 000 persons of 187 inspital ‘‘Nuestra Sen˜ora de La Altagracia’’ in Santo Domingo, Dominican Republic, the
ric Department of Zacamil National Hospital and ‘‘Hospital Nacional de la Mujer’’ in
ra Sen˜ora de La Altagracia’’
ity Hospital,
ican Republic
University Hospital
‘‘Hernando Moncaleano
Perdomo’’, Colombia
n = 37
Total
All institutions
combined
n = 169
n (%) n (%)
0%) 37 (100%) 169 (100.0%)
0%) 36 (97.3%) 167 (98.8%)
0%) 37 (100%) 164 (98.2%)
.0%) 36 (97.3%) 115 (68.0%)
.0%) 5 (13.5%) 97 (57.4%)
.8%) 10 (27.0%) 89 (52.7%)
1 (2.7%) 29 (17.2%)
%) 2 (5.4%) 17 (10.1%)
.1%) 1(2.7%) 13 (7.7%)
%) 1 (2.7%) 12 (7.1%)
%) - 4 (2.4%)
%) 2 (5.4%) 3 (1.8%)
a’’ Maternity Hospital suspected chikungunya fever cases and conﬁrmed cases at the
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cumulated causes of encephalitis in the USA in this age category),
with a CFR of 16.6%, has been reported recently based on the
experience of the large epidemic observed in La Re´union Island.
The proportion of children discharged with persistent disabilities
was estimated at between 30% and 45%.11
Vertical transmission rates in the present series (27.2% to
48.29%) were similar to those reported previously in the literature
(47%). Nonetheless, the CFR observed (5.3%) is signiﬁcantly greater
than reported previously in La Re´union Island in 2006 (ranging
from 0.8% (5/658) to 2.6% (1/38)) and in Colombo, Sri Lanka in
2007 in which no deaths were described.12–15
A recent study in Colombia aimed at characterizing CHIKF in
children and detecting differences in presentation and severity
between neonates and other age groups, showed that both
hemoglobin and hematocrit levels were signiﬁcantly lower in
the group of neonates with conﬁrmed CHIKV infection, and platelet
counts were abnormally low (<100  109/l) in 20% of them
(p = 0.040). Rash was signiﬁcantly more frequent in neonates than
in other children with conﬁrmed CHIKF, and the interquartile
range (IQR) of viral load was also higher (p = 0.030). Neonates had
an adjusted relative risk of being admitted to critical care of 7.77
(95% conﬁdence interval 1.37–43.79), as compared to the other age
groups. Some of the results of this study have been published
recently.16
Recent estimates, also from Colombia, suggest a high economic
impact of pediatric infection in this region. Indeed, the average cost
per uncomplicated CHIKF case was US$ 517.5 for children 1 year
of age and US$ 375.1 for children <1 year old. The average length of
stay was 2.7 days per patient.17
The prognosis of uninfected children born to mothers infected by
CHIKV during pregnancy is identical to that of children exposed in
utero to maternal fever, for which there is currently no convincing
evidence of subsequent neurocognitive impairment. However, in
neonates diagnosed with CHIKF, long-term follow-up is needed,
given the implications of potential long-term sequelae, such as
neurocognitive impairment, microcephaly, and cerebral palsy.11
One obvious limitation of this series is the lack of conﬁrmatory
results in a large proportion of the cases. However, all patients
were seen during the peak of a well-documented epidemic of
CHIKV, and many of them showed characteristic clinical ﬁndings
such as a distinct rash, hyperalgesia syndrome, diffuse inﬂamma-
tory lower limb edema, and bullous dermatosis, all of these
considered hallmarks of neonatal CHIKF.13,14 Moreover, confound-
ing factors like dengue fever were routinely excluded in all
mothers and newborns, and Zika virus was not present in the
Western Hemisphere at that time.
It must be highlighted that with few exceptions, the frequency
of clinical ﬁndings seen in suspected cases was similar to that of
conﬁrmed patients in this series. Although rash and meningoen-
cephalitis were clearly signiﬁcantly less common in the former, it
can be argued that hyperalgesia or allodynia, also seen less often in
suspected cases, may easily be missed or underestimated by a less
meticulous clinician.These results may help public health ofﬁcials, obstetricians,
pediatricians, and infectious disease specialists who provide care
for pregnant women or newborns in the region. In countries
experiencing epidemics of CHIKF, clinicians must be familiar with
the possibility of mother-to-child transmission and its conse-
quences, as such knowledge may help to improve its future
management and strengthen mitigation strategies.
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